Table 2.
Statistically significant comparisons in demographics, main COVID-19 related symptoms, medications and comorbidities between patients requiring hospitalization and those recovered at home.
| Patients required hospitalization (n = 18) | Patients recovered at home (n = 59) | p-value | |
|---|---|---|---|
| Demographics | |||
| Age (mean ± SD, years) | 63.9 ± 14.4 | 45.1 ± 15.0 | <0.001 |
| COVID-19 symptoms | |||
| Fever low grade (%) | 16.7 | 54.2 | 0.005 |
| Fever high grade (%) (>38 °C, %) | 72.2 | 18.6 | <0.001 |
| Anosmia (%) | 5.6 | 37.3 | 0.01 |
| Shortness of breath (%) | 38.9 | 6.8 | <0.001 |
| Confusion (%) | 5.5 | 0.0 | 0.016 |
| Medications | |||
| Methylprednisolone (%) | 61.1 | 25.4 | 0.005 |
| Azathioprine or Mycophenolate mofetil (%) | 44.4 | 13.6 | 0.005 |
| Mycophenolate mofetil (%) | 33.3 | 5.1 | 0.001 |
| Comorbidities | |||
| Lung disease (%) | 44.4 | 5.1 | <0.001 |
| Dyslipidemia (%) | 22.2 | 3.7 | 0.014 |